Related Experiment Video

Updated: Mar 30, 2026

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel
06:44

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel

Published on: September 8, 2017

14.2K

[The mechanisms of drug resistance in prostate cancer]

Yang He, Yang-guang Liu, Shan Cen

    Yao Xue Xue Bao = Acta Pharmaceutica Sinica
    |November 11, 2015
    PubMed

    Insights

    Drug resistance is a major challenge in prostate cancer treatment. This review explores resistance mechanisms to identify new therapeutic strategies and targets for effective prostate cancer therapy.

    Area of Science:

    • Oncology
    • Pharmacology
    • Molecular Biology

    Background:

    • Drug therapy is a primary treatment for prostate cancer.
    • Drug resistance significantly impedes treatment efficacy and patient outcomes.
    • Understanding resistance mechanisms is crucial for advancing prostate cancer care.

    Purpose of the Study:

    • To comprehensively review the mechanisms of drug resistance in prostate cancer.
    • To identify potential alternative therapeutic strategies.
    • To highlight novel targets for anti-prostate cancer drug development.

    Main Methods:

    • Literature review of existing research on prostate cancer drug resistance.
    • Analysis of molecular and cellular mechanisms underlying resistance.
    • Synthesis of findings to propose new therapeutic avenues.

    Main Results:

    • Detailed examination of various drug resistance pathways in prostate cancer.
    • Identification of key molecular players contributing to treatment failure.
    • Compilation of a broad spectrum of resistance mechanisms.

    Conclusions:

    • Elucidating drug resistance mechanisms offers critical insights for improving prostate cancer treatment.
    • This review provides a foundation for developing novel therapeutic strategies and drug targets.
    • Targeting identified resistance mechanisms may overcome treatment limitations in prostate cancer patients.

    More Related Videos

    Prostate Organoid Cultures as Tools to Translate Genotypes and Mutational Profiles to Pharmacological Responses08:36

    Prostate Organoid Cultures as Tools to Translate Genotypes and Mutational Profiles to Pharmacological Responses

    Published on: October 24, 2019

    11.8K
    Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms08:46

    Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

    Published on: December 9, 2015

    11.3K

    Related Concept Videos

    Treatment Resistant Cancers02:56

    Treatment Resistant Cancers

    Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
    3.9K
    Adaptive Mechanisms in Cancer Cells02:53

    Adaptive Mechanisms in Cancer Cells

    4.3K
    Adaptive Mechanisms in Cancer Cells02:53

    Adaptive Mechanisms in Cancer Cells

    Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
    Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
    7.4K
    Mechanism of Antibiotic Resistance in MRSA01:25

    Mechanism of Antibiotic Resistance in MRSA

    Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
    99
    Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

    Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

    Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
    68
    Factors Affecting Drug Distribution: Physiological Barriers01:23

    Factors Affecting Drug Distribution: Physiological Barriers

    Drug distribution in the body is intricately regulated by various physiological barriers that control the passage of substances. These include the capillary endothelial barrier, the blood-brain, blood-cerebrospinal fluid, blood-placental, and blood-testis barriers.
    The capillary endothelial barrier allows only smaller molecules below 600 Da (Daltons) to pass through. It also restricts drugs like heparin that are bound to blood components, limiting their movement within the bloodstream.
    The...
    938